ARTICLE
|
doi:10.20944/preprints202310.1682.v1
Subject:
Medicine And Pharmacology,
Gastroenterology And Hepatology
Keywords:
Atezolizumab; bevacizumab; non-alcoholic fatty liver disease; non-alcoholic steato hepatitis; albumin-bilirubin (ALBI) score
Online: 26 October 2023 (09:01:45 CEST)